Selected research
Industry Research
Laboratory Developed Tests (LDT) Industry Research Report 2026
Market perspective
The global Laboratory Developed Tests (LDT) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Laboratory Developed Tests (LDT) market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Laboratory Developed Tests (LDT) market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Laboratory Developed Tests (LDT) market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Laboratory Developed Tests (LDT) include Quest Diagnostics, Thermo Fisher, Waters Corporation, Roche, Illumina, Qiagen, Eurofins, Guardant Health and Adaptive Biotechnologies, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Laboratory Developed Tests (LDT) market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Laboratory Developed Tests (LDT).
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Laboratory Developed Tests (LDT) Market by Company
Quest Diagnostics
Thermo Fisher
Waters Corporation
Roche
Illumina
Qiagen
Eurofins
Guardant Health
Adaptive Biotechnologies
Biodesix
Berry Oncology
Genetron Health
Laboratory Developed Tests (LDT) Segment by Type
Clinical Biochemistry
Hematology
Immunology
Molecular Diagnostics
Other
Laboratory Developed Tests (LDT) Segment by Application
Hospitals Laboratory
Clinical Research Organizations
Academic Institutes
Specialty Diagnostic Centers
Other
Laboratory Developed Tests (LDT) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Laboratory Developed Tests (LDT) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Laboratory Developed Tests (LDT) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Laboratory Developed Tests (LDT).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Laboratory Developed Tests (LDT) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Clinical Biochemistry
- Hematology
- Immunology
- Molecular Diagnostics
- Other
Applications
- Hospitals Laboratory
- Clinical Research Organizations
- Academic Institutes
- Specialty Diagnostic Centers
- Other
Companies covered
- Quest Diagnostics
- Thermo Fisher
- Waters Corporation
- Roche
- Illumina
- Qiagen
- Eurofins
- Guardant Health
- Adaptive Biotechnologies
- Biodesix
- Berry Oncology
- Genetron Health
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Laboratory Developed Tests (LDT) by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Clinical Biochemistry
- 2.2.3 Hematology
- 2.2.4 Immunology
- 2.2.5 Molecular Diagnostics
- 2.2.6 Other
- 2.3 Laboratory Developed Tests (LDT) by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospitals Laboratory
- 2.3.3 Clinical Research Organizations
- 2.3.4 Academic Institutes
- 2.3.5 Specialty Diagnostic Centers
- 2.3.6 Other
- 2.4 Assumptions and Limitations
3 Laboratory Developed Tests (LDT) Breakdown Data by Type
- 3.1 Global Laboratory Developed Tests (LDT) Historic Market Size by Type (2021-2026)
- 3.2 Global Laboratory Developed Tests (LDT) Forecasted Market Size by Type (2027-2032)
4 Laboratory Developed Tests (LDT) Breakdown Data by Application
- 4.1 Global Laboratory Developed Tests (LDT) Historic Market Size by Application (2021-2026)
- 4.2 Global Laboratory Developed Tests (LDT) Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Laboratory Developed Tests (LDT) Market Perspective (2021-2032)
- 5.2 Global Laboratory Developed Tests (LDT) Growth Trends by Region
- 5.2.1 Global Laboratory Developed Tests (LDT) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Laboratory Developed Tests (LDT) Historic Market Size by Region (2021-2026)
- 5.2.3 Laboratory Developed Tests (LDT) Forecasted Market Size by Region (2027-2032)
- 5.3 Laboratory Developed Tests (LDT) Market Dynamics
- 5.3.1 Laboratory Developed Tests (LDT) Industry Trends
- 5.3.2 Laboratory Developed Tests (LDT) Market Drivers
- 5.3.3 Laboratory Developed Tests (LDT) Market Challenges
- 5.3.4 Laboratory Developed Tests (LDT) Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Laboratory Developed Tests (LDT) Players by Revenue
- 6.1.1 Global Top Laboratory Developed Tests (LDT) Players by Revenue (2021-2026)
- 6.1.2 Global Laboratory Developed Tests (LDT) Revenue Market Share by Players (2021-2026)
- 6.2 Global Laboratory Developed Tests (LDT) Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Laboratory Developed Tests (LDT) Head Office and Area Served
- 6.4 Global Laboratory Developed Tests (LDT) Players, Product Type & Application
- 6.5 Global Laboratory Developed Tests (LDT) Manufacturers Established Date
- 6.6 Global Laboratory Developed Tests (LDT) Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Laboratory Developed Tests (LDT) Market Size (2021-2032)
- 7.2 North America Laboratory Developed Tests (LDT) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Laboratory Developed Tests (LDT) Market Size by Country (2021-2026)
- 7.4 North America Laboratory Developed Tests (LDT) Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Laboratory Developed Tests (LDT) Market Size (2021-2032)
- 8.2 Europe Laboratory Developed Tests (LDT) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Laboratory Developed Tests (LDT) Market Size by Country (2021-2026)
- 8.4 Europe Laboratory Developed Tests (LDT) Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Laboratory Developed Tests (LDT) Market Size (2021-2032)
- 9.2 Asia-Pacific Laboratory Developed Tests (LDT) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Laboratory Developed Tests (LDT) Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Laboratory Developed Tests (LDT) Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Laboratory Developed Tests (LDT) Market Size (2021-2032)
- 10.2 South America Laboratory Developed Tests (LDT) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Laboratory Developed Tests (LDT) Market Size by Country (2021-2026)
- 10.4 South America Laboratory Developed Tests (LDT) Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Laboratory Developed Tests (LDT) Market Size (2021-2032)
- 11.2 Middle East & Africa Laboratory Developed Tests (LDT) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Laboratory Developed Tests (LDT) Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Laboratory Developed Tests (LDT) Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Quest Diagnostics
- 12.1.1 Quest Diagnostics Company Information
- 12.1.2 Quest Diagnostics Business Overview
- 12.1.3 Quest Diagnostics Revenue in Laboratory Developed Tests (LDT) Business (2021-2026)
- 12.1.4 Quest Diagnostics Laboratory Developed Tests (LDT) Product Portfolio
- 12.1.5 Quest Diagnostics Recent Developments
- 12.2 Thermo Fisher
- 12.2.1 Thermo Fisher Company Information
- 12.2.2 Thermo Fisher Business Overview
- 12.2.3 Thermo Fisher Revenue in Laboratory Developed Tests (LDT) Business (2021-2026)
- 12.2.4 Thermo Fisher Laboratory Developed Tests (LDT) Product Portfolio
- 12.2.5 Thermo Fisher Recent Developments
- 12.3 Waters Corporation
- 12.3.1 Waters Corporation Company Information
- 12.3.2 Waters Corporation Business Overview
- 12.3.3 Waters Corporation Revenue in Laboratory Developed Tests (LDT) Business (2021-2026)
- 12.3.4 Waters Corporation Laboratory Developed Tests (LDT) Product Portfolio
- 12.3.5 Waters Corporation Recent Developments
- 12.4 Roche
- 12.4.1 Roche Company Information
- 12.4.2 Roche Business Overview
- 12.4.3 Roche Revenue in Laboratory Developed Tests (LDT) Business (2021-2026)
- 12.4.4 Roche Laboratory Developed Tests (LDT) Product Portfolio
- 12.4.5 Roche Recent Developments
- 12.5 Illumina
- 12.5.1 Illumina Company Information
- 12.5.2 Illumina Business Overview
- 12.5.3 Illumina Revenue in Laboratory Developed Tests (LDT) Business (2021-2026)
- 12.5.4 Illumina Laboratory Developed Tests (LDT) Product Portfolio
- 12.5.5 Illumina Recent Developments
- 12.6 Qiagen
- 12.6.1 Qiagen Company Information
- 12.6.2 Qiagen Business Overview
- 12.6.3 Qiagen Revenue in Laboratory Developed Tests (LDT) Business (2021-2026)
- 12.6.4 Qiagen Laboratory Developed Tests (LDT) Product Portfolio
- 12.6.5 Qiagen Recent Developments
- 12.7 Eurofins
- 12.7.1 Eurofins Company Information
- 12.7.2 Eurofins Business Overview
- 12.7.3 Eurofins Revenue in Laboratory Developed Tests (LDT) Business (2021-2026)
- 12.7.4 Eurofins Laboratory Developed Tests (LDT) Product Portfolio
- 12.7.5 Eurofins Recent Developments
- 12.8 Guardant Health
- 12.8.1 Guardant Health Company Information
- 12.8.2 Guardant Health Business Overview
- 12.8.3 Guardant Health Revenue in Laboratory Developed Tests (LDT) Business (2021-2026)
- 12.8.4 Guardant Health Laboratory Developed Tests (LDT) Product Portfolio
- 12.8.5 Guardant Health Recent Developments
- 12.9 Adaptive Biotechnologies
- 12.9.1 Adaptive Biotechnologies Company Information
- 12.9.2 Adaptive Biotechnologies Business Overview
- 12.9.3 Adaptive Biotechnologies Revenue in Laboratory Developed Tests (LDT) Business (2021-2026)
- 12.9.4 Adaptive Biotechnologies Laboratory Developed Tests (LDT) Product Portfolio
- 12.9.5 Adaptive Biotechnologies Recent Developments
- 12.10 Biodesix
- 12.10.1 Biodesix Company Information
- 12.10.2 Biodesix Business Overview
- 12.10.3 Biodesix Revenue in Laboratory Developed Tests (LDT) Business (2021-2026)
- 12.10.4 Biodesix Laboratory Developed Tests (LDT) Product Portfolio
- 12.10.5 Biodesix Recent Developments
- 12.11 Berry Oncology
- 12.11.1 Berry Oncology Company Information
- 12.11.2 Berry Oncology Business Overview
- 12.11.3 Berry Oncology Revenue in Laboratory Developed Tests (LDT) Business (2021-2026)
- 12.11.4 Berry Oncology Laboratory Developed Tests (LDT) Product Portfolio
- 12.11.5 Berry Oncology Recent Developments
- 12.12 Genetron Health
- 12.12.1 Genetron Health Company Information
- 12.12.2 Genetron Health Business Overview
- 12.12.3 Genetron Health Revenue in Laboratory Developed Tests (LDT) Business (2021-2026)
- 12.12.4 Genetron Health Laboratory Developed Tests (LDT) Product Portfolio
- 12.12.5 Genetron Health Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst